Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma

Published:2008-08 Issue:8 Volume:14 Page:1107-1115
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Toso Christian,Trotter James,Wei Alice,Bigam David L.,Shah Shimul,Lancaster Joshua,Grant David R.,Greig Paul D.,Shapiro A. M. James,Kneteman Norman M.

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference20 articles.

1. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

2. Result of liver transplantation: with or without Milan criteria?;Mazzaferro;Liver Transpl,2007

3. Liver transplantation for hepatocellular carcinomas: expansion of the tumor size limits does not adversely impact survival;Yao;Hepatology,2001

4. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study;Leung;Liver Transpl,2004

5. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria;Ravaioli;Liver Transpl,2004

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Transplantation for Hepatocarcinoma: Results over Two Decades of a Transplantation Programme and Analysis of Factors Associated with Recurrence;Biomedicines;2024-06-12

2. Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT);Updates in Surgery;2024-05-07

3. Transplantation for Hepatocellular Carcinoma;Surgical Clinics of North America;2024-02

4. Transplant oncology – Current indications and strategies to advance the field;JHEP Reports;2024-02

5. Role of temporary portosystemic surgical shunt during liver resection to prevent a post-resection small for size-like syndrome;Hepatoma Research;2024